Interestingly, the expression of the TTCC Cav3.1 isoform was significantly correlated to the autophagic status in BRAFi-resistant CM tissues and cells, and in silico analysis revealed an enrichment of Cav3.1 expression in CM following treatment with BRAFi [57]. The gene discussed is CACNA1G; the disease is cutaneous mastocytosis.